The impact of microRNAs and alternative splicing in pharmacogenomics

Pharmacogenomics J. 2009 Feb;9(1):1-13. doi: 10.1038/tpj.2008.14.

Authors

F Passetti¹, C G Ferreira, F F Costa

Affiliation

¹ Laboratory of Bioinformatics and Computational Biology, Division of Clinical and Translational Research, Research Coordination (CPQ), Instituto Nacional de Câncer, Rio de Janeiro, Brazil.

PMID: 19156160
DOI: 10.1038/tpj.2008.14

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Alternative Splicing / genetics
Alternative Splicing / physiology*
Drug Resistance / genetics*
Humans
MicroRNAs / genetics
MicroRNAs / physiology*
Pharmacogenetics / methods*
Polymorphism, Single Nucleotide

Substances

MicroRNAs